NXGL (NEXGEL) Net Profit

Official company branding of NEXGEL (NXGL)

NEXGEL, Inc. is optimizing its operations through contract manufacturing and third-party logistics. The localization of capacities in the US eliminates the impact of trade conflicts. The business is forging strong ties with brands through its unique hydrogels. The company's annual profit demonstrates financial stability, while -0.01 represents the latest value for this metric.

NXGL: NEXGEL Inc Net Income 07/04/2022 - 10/29/2026

Analytical breakdowns and data insights for company NEXGEL (NXGL)

- price and consensus price forecast:
Stock Quotes NEXGEL Inc|NXGL - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization NEXGEL Inc|NXGL - Total Company Value
- book capitalization data:
Net Assets per Single Share NEXGEL|NXGL - Company Net Assets|Market Value to Book Value nexgel.com|NXGL - Company Total Assets
- debt and liquidity details:
Total Debt to Capital Coefficient NEXGEL, Inc.|NXGL - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio NEXGEL Inc.|NXGL - Company Debts|Debts to Net Assets NEXGEL Inc|NXGL - Company Long-Term Liabilities|Amount of Current Liabilities NEXGEL|Intermediate Coverage Ratio nexgel.com
- earnings and valuation multiples information:
NXGL - Net Income
Basic company analysis:NXGL - NEXGEL Inc
Mass-produced product of NEXGEL Inc

For the conservative investor, the calculated profit of -0.01 serves as a benchmark for real operational efficiency, reflecting the daily cash balance after all expenses. By analyzing the balance sheet profit of NEXGEL, Inc. (NXGL) through GURU.Markets tools, one can confirm the business resilience of NEXGEL, Inc. (NXGL), where the localization of production in the US mitigates logistical risks, ensuring a stable capital inflow and the long-term financial reliability of the issuer.

Key competitors

Net Income Intuitive Corp|DHR (Danaher Corp.) - Net Profit|Net Profit bd.com|Company Net Income STERIS (STE)|Company Net Income WST (West Pharma)|Baxter Corp - Net Income|Final Profit MASI|Stevanato Group S.p.A. - Net Profit|Net Financial Result teleflex.com TFX|Merit Medical (MMSI) - Company Net Income|Company Profit NVST|Company Net Income ICU Medical Corp|Sirona Dental Systems (XRAY) - Net Financial Result|Net Income LMAT (LeMaitre Vascular, Inc.)|Profit After Payment of Taxes ATRC|Company Net Income STAAR Surgical STAA|Final Profit NAGE|ZIMV: Net Income|ANGO - Net Profit|Cerus Corporation (CERS) - Company Net Income|Net Income teknova.com|MGRM (Monogram Orthopedics) - Net Profit|Company Net Income Sharps Tech STSS|Company Net Income InfuSystem Holdings (INFU)|Utah Med - Company Profit|KORU Medical - Net Income|Profit After Payment of Taxes NYXH (nyxoah.com)|MBOT - Company Net Income|Net Financial Result Pro-Dex Inc PDEX|Zentek Limited (ZTEK) - Company Net Income|Company Profit ELUT|MLSS (Milestone Scientific) - Net Profit|Company Net Income Retractable Tech RVP|Net Income HBIO (Harvard Bioscience, Inc.)|Femasys Inc - Company Profit|Net Profit MHUA (Meihua Medical Technologies Co., Ltd.)|Annual Net Income Predictive Oncology Inc|Callan JMB Corp - Net Profit|Company Net Income atrioncorp.com|NeuroMetrix (NURO) - Company Net Income